Table 1.
LQT1 (n=29) | LQT2 (n=21) | Control (n=108) | |
---|---|---|---|
Mean age±SD | 10.4±4.2 | 11.7±4.7 | 11.8±3.6 |
Female sex, n (%) | 19(61) | 11(52) | 45(42) |
Beta-blocker usage, n (%) | 17(59) | 11(52) | |
Rest (QTc ms±SD) | 452±33† | 475±35†* | 407±21 |
Peak exercise | 488±35† | 439±32†* | 406±25 |
1 min recovery | 481±35† | 434±27†* | 401±22 |
3 min recovery | 491±38† | 460±34†* | 408±22 |
5 min recovery | 487±32† | 468±22†* | 427±19 |
7 min recovery | 484±29† | 478±20† | 431±18 |
9 min recovery | 486±32† | 473±23† | 432±18 |
P-value <0.001 LQT1 and LQT2 vs controls
P-value <0.001 LQT1 vs LQT2